JWK-006

N/A

Report date: 2024/04/28 20:00:08

Base Information

Drug NameJWK-006
Drug Alias NameJWK006JWK-006
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRetinal-specific phospholipid-transporting ATPase ABCA4 gene transference
TargetsRetinal-specific phospholipid-transporting ATPase ABCA4
Therapy Area/IndicationsStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Genevector Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Genevector Biotechnology Co Ltd
Inactive CompaniesWest China Hospital Of Sichuan University
Active IndicationsStargardt Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A